Here you will find copies of all the ASX Announcements made by Bio-Gene (ASX:BGT) between 1 January 2021 and 31 December 2021
17-12-2021 EGM 27 January 2022 - Letter/NOM/Proxy
17-12-2021 Cleansing Statement
17-12-2021 Appendix 2A - Share Placement
09-12-2021 Appendix 3B
09-12-2021 BIO-GENE COMPLETES CAPITAL RAISING OF $3.2 MILLION TO ACCELERATE DEVELOPMENT ACTIVITY
06-12-2021 BIO-GENE TO PROGRESS SYNERGY RESEARCH
01-12-2021 Appendix 3G
01-12-2021 BIO-GENE VIRTUAL PRESENTATION AT V-CON
30-11-2021 Bio-Gene 2021 AGM - Results of Meeting
30-11-2021 Bio-Gene 2021 AGM - CEO's Presentation
30-11-2021 Bio-Gene 2021 AGM - Chairman's Address
30-11-2021 Bio-Gene 2021 AGM Presentation
29-10-2021 Notice of Annual General Meeting 2021
28-10-2021 Bio-Gene Investor Briefing
28-10-2021 Appendix 4C - 30 September 2021
27-10-2021 BIO-GENE TECHNOLOGY INVESTOR BRIEFING
27-10-2021 BIO-GENE ENTERS INTO OPTION AGREEMENT WITH CLARKE FOR PUBLIC HEALTH MOSQUITO CONTROL IN THE UNITED STATES
25-10-2021 BIO-GENE EXECUTES COMMERCIAL DEVELOPMENT AGREEMENT WITH EVERGREEN GARDEN CARE
14-10-2021 Successful Allowance Of New United States Patent
12-10-2021 NOTICE REQUIRED UNDER ASX LISTING RULE 3.13.1
31-08-2021 Bio-Gene to Present at Australian Mosquito Control Symposium
26-08-2021 Appendix 4G and 2021 Corporate Governance Statement
26-08-2021 Appendix 4E and 2021 Annual Report
30-07-2021 CLARIFICATION OF SHARE BUY-BACK NOTICES
29-07-2021 Appendix 3C - Notification of Share Buy-back
29-07-2021 Appendix 3C - Notification of Share Buy-back
21-07-2021 Appendix 4C - 30 June 2021
09-06-2021 Successful Allowance of Additional New Australian Patent
08-06-2021 SUCCESSFUL ALLOWANCE OF NEW AUSTRALIAN PATENT
13-05-2021 Bio-Gene Company Briefing
12-05-2021 STORED GRAIN TRIAL INTERIM RESULTS CONFIRM CONTROL OF KEY PESTS
06-05-2021 Appendix 3G
06-05-2021 Terms of Options
06-05-2021 Appendix 3B
30-04-2021 Appendix 4C - 31 March 2021
26-04-2021 Initial Director's Interest Notice - A Guthrie
26-04-2021 Appointment of Non-executive Director
15-04-2021 Bio-Gene Presenting at Monsoon Twilight Investor Briefing
01-03-2021 Change of Director's Interest - R Klupacs
01-03-2021 Initial Director's Interest Notice - J Joughin
25-02-2021 Appointment of Non-executive Director
24-02-2021 FLAVOCIDE™ MODE OF ACTION STUDIES CONFIRM DEFINITIVE TARGET SITE OF ACTIVITY
18-02-2021 Appendix 4D - Half Year Reports and Financial Statements - 31/12/20
29-01-2021 Appendix 4C - 31 December 2020
21-01-2021 RESULTS OF LATEST ECO-TOXICITY STUDIES REINFORCE ENVIRONMENTAL SAFETY PROFILE OF FLAVOCIDE™
ASX Announcements Archive - 1 January 2020 to 31 December 2020
ASX Announcements Archive - 1 January 2019 to 31 December 2019
ASX Announcements Archive - 29 November 2017 to 31 December 2018
To be alerted about our ASX Announcements and other news on Bio-Gene you can join our mailing list here: